Oneness Biotech Co., Ltd. (TPEX:4743)
45.75
-1.70 (-3.58%)
Aug 5, 2026, 1:30 PM CST
Oneness Biotech Market Cap
Oneness Biotech has a market cap or net worth of 21.93 billion as of August 5, 2026. Its market cap has decreased by -26.86% in one year.
Market Cap
21.93B
Enterprise Value
17.07B
Revenue
140.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
45.75
ChartMarket Cap Chart
Since June 22, 2009, Oneness Biotech's market cap has increased from 1.24B to 21.93B, an increase of 1,669.02%. That is a compound annual growth rate of 18.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 21.93B | -17.55% |
| Dec 31, 2025 | 26.60B | -36.18% |
| Dec 31, 2024 | 41.68B | -52.65% |
| Dec 29, 2023 | 88.03B | -7.55% |
| Dec 30, 2022 | 95.22B | -13.04% |
| Dec 30, 2021 | 109.49B | 21.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 24.72B |
| Sunmax Biotechnology | 20.75B |
| TaiMed Biologics | 15.74B |
| Medigen Vaccine Biologics | 15.58B |
| Ever Supreme Bio Technology | 15.11B |
| Lumosa Therapeutics | 14.69B |
| EirGenix | 14.36B |
| ACRO Biomedical | 13.32B |